A61K 38/10
Peptides having 12 to 20 amino acids
Official title: Peptides having 12 to 20 amino acids {(A61K38/043 - A61K38/046 take precedence)}
A61K38/10 (Peptides having 12 to 20 amino acids) appears on 1,762 US grants and 3,105 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,762
- Published applications
- 3,105
- Assignees
- 1,233
- Inventors
- 4,578
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 8 | 0 |
| 1999 | 8 | 0 |
| 2000 | 10 | 0 |
| 2001 | 8 | 5 |
| 2002 | 9 | 15 |
| 2003 | 9 | 41 |
| 2004 | 7 | 39 |
| 2005 | 21 | 47 |
| 2006 | 27 | 50 |
| 2007 | 27 | 65 |
| 2008 | 20 | 69 |
| 2009 | 35 | 87 |
| 2010 | 40 | 117 |
| 2011 | 34 | 113 |
| 2012 | 45 | 100 |
| 2013 | 65 | 183 |
| 2014 | 111 | 187 |
| 2015 | 112 | 181 |
| 2016 | 144 | 243 |
| 2017 | 136 | 204 |
| 2018 | 116 | 178 |
| 2019 | 147 | 188 |
| 2020 | 137 | 230 |
| 2021 | 117 | 156 |
| 2022 | 107 | 166 |
| 2023 | 81 | 115 |
| 2024 | 81 | 149 |
| 2025 | 59 | 103 |
| 2026 | 35 | 74 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Pharmaceutical composition for treatment or prevention of ischemic cardiovascular disease29 Sep 2026US 12,746,220 B2Industry-Academic Cooperation Foundation, Yonsei University
- Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations29 Sep 2026US 12,746,268 B2Nymox Corporation
- Use of polypeptide in drug for preventing and treating pneumonia15 Sep 2026US 12,734,211 B2Nanning Genloci Biomedical Co., Ltd.
- Hemostatic elastin-like polypeptides15 Sep 2026US 12,735,455 B2UniversitäT Basel
- Peptide tags for ligand induced degradation of fusion proteins15 Sep 2026US 12,735,463 B2Dana-Farber Cancer Institute, Inc.
- Subcutaneous peptide delivery system8 Oct 2026US 2026/0306408 A1
- Compositions and methods for treatment of septic shock8 Oct 2026US 2026/0306579 A1Peroxitech Therapeutics, Inc.
- Compositions and methods for treatment of systemic lupus erythematosus1 Oct 2026US 2026/0295001 A1
- Histatin for corneal wound healing and ocular surface disease1 Oct 2026US 2026/0295005 A1Visus Therapeutics, Inc.
- Apelin polypeptides1 Oct 2026US 2026/0297132 A1Amgen Inc.
Most cited
By later US patents
- Modular pressure support system184US 7,677,246 B2RIC Investments, LLC · 2010
- Chimeric NK receptor and methods for treating cancer159US 7,994,298 B2Trustees of Dartmouth College · 2011
- Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders138US 6,037,323 A2000
- Immunostimulatory combinations138US 7,387,271 B23M Innovative Properties Company · 2008
- Chimeric NK receptor and methods for treating cancer128US 8,252,914 B2Trustees of Dartmouth College · 2012